Year-end Report January-December 2010
(Thomson Reuters ONE) -
Period October-December
· The Group's net sales for the period were SEK 142 (153) million. After
adjustment for the disposal of the OTC products, organic growth was 9%.
· EBITDA for the period amounted to SEK 21* (23) million. After adjustment for
the disposal of the OTC products and closing-down costs in Poland, EBITDA
amounted to SEK 24 (14) million.
· Operating profit was SEK 7** (13) million.
· Profit after tax for the period was SEK 0*** (2) million.
· Earnings per share after tax, before and after dilution, for the period was
SEK 0.00 (0.01).
Period January-December
· The Group's net sales for the period were SEK 553 (634) million.
· EBITDA for the period amounted to SEK -16* (98) million.
· Operating profit/loss was SEK -122** (71) million.
· Profit/loss after tax for the period was SEK -163*** (18) million.
· Earnings per share after tax, before and after dilution, for the period was
SEK -0.48 (0.05).
Significant events during the period January-December
· The Board decided to streamline operations and focus on prescription
pharmaceuticals in the Nordic region. These measures resulted in a strong fourth
quarter for BioPhausia.
· BioPhausia sold OTC products to Meda AB for SEK 190 million, resulting in a
capital loss of SEK 74 million.
· Bank loan repayments amounted to SEK 245 million during the period.
· BioPhausia became the main supplier of parallel-imported pharmaceuticals to
Apoteksgruppen.
· Impairment losses of SEK 82 million were recognised for intangible assets and
SEK 18 million for inventories.
· Niklas Prager was elected as the new Chairman of the Board of BioPhausia.
· Maris Hartmanis took up the position of BioPhausia CEO on 9 August.
Year-end Report January?December 2010:
http://hugin.info/130049/R/1490107/425725.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BioPhausia AB via Thomson Reuters ONE
[HUG#1490107]
Unternehmensinformation / Kurzprofil:
Datum: 17.02.2011 - 14:01 Uhr
Sprache: Deutsch
News-ID 51634
Anzahl Zeichen: 2701
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 179 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Year-end Report January-December 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
BioPhausia AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
